News
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Researchers say that a pair of already FDA-approved medications could reverse brain changes in the most common form of ...
10don MSNOpinion
FDA Commissioner: 100 Days of Change—Modernizing the FDA for a Healthier America | Opinion
The Food and Drug Administration (FDA) can maintain its high bar for safety and efficacy, and also cut the waste and ...
12d
MedPage Today on MSNFDA Approves Label Change for Alzheimer's Amyloid Drug
The FDA approved a label update with a new titration schedule for donanemab (Kisunla), an anti-amyloid drug approved to treat ...
Obtaining FDA clearance or approval is just the beginning of a company’s regulatory journey. As FDA-regulated products evolve, changes to ...
FDA Commissioner Marty Makary, M.D., has made his pick for the next director of the FDA’s Center for Drug Evaluation and ...
The standard threshold for approval in an FDA clinical trial is a false positive rate of 2.5 percent or less; in other words, the FDA is willing to tolerate approving ineffective drugs 2.5 percent ...
While we all value the fact that the FDA goes to great lengths to ensure the safety and efficacy of new drugs, the process can often drag on for over a decade, depriving people of live-saving drugs.
How FDA approval will change COVID-19 ... In its review for approval, the U.S. Food and Drug Administration analyzed clinical trial data from about 20,000 vaccine recipients and concluded ...
Last week, the U.S. Food and Drug Administration (FDA) finalized guidance on the types of information that should be included in a Predetermined Change Control Plan (PCCP) as part of a marketing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results